G01N2333/96413

IN VITRO QUALITY SCREENING OF HUMAN CORNEAL STROMAL STEM CELLS FOR CELL-BASED THERAPY OF CORNEAL SCARRING

The present disclosure relates to a method of determining effectiveness of corneal stromal stem cell therapy through evaluation of stem cell markers, inflammation markers, and assessing a scarring index.

Activators of caspase-8/c-FLIP.SUB.L dimerization and their use in cancer therapy

The present invention relates to activators of caspase-8/c-FLIP.sub.L dimerization and their use in enhancing the pro-apoptotic activity of the heterodimer and cancer therapy.